ConocoPhillips
—- Market cap
- $164.63B
- Debt
- —
- Cash
- −$6.50B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $164.63B · View financials
Snapshot Sep 10, 2026, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: COP stock price near parity vs PSX $137.04 current versus $152.14 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PSX's multiple
Implied fair value · at COP's multiple
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Lower P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 84% equity / 16% debt · EV / Revenue 0.92x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ConocoPhillips · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Phillips 66 · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe the market should continue to price superior profitability and growth into multiples (i.e., COP's higher margins and positive revenue growth are sustainable), then buy COP because it has higher net income ($8.0B vs $4.4B), materially higher margins (gross 62.1% vs 12.3%, net 13.6% vs 3.3%) and lower leverage (Debt/Equity 0.2x vs 0.7x), otherwise avoid or trim COP because a re-rate to PSX's P/E (14.7x) would imply ~21.3% downside to $93.43.
COP is trading above the price implied by applying PSX multiples (implied price $93.43 vs current $118.79), producing a ~21.3% downside if the market re-rates COP to PSX's P/E. The premium is evident on earnings and revenue multiples (P/E and P/S) though EV/EBITDA is actually slightly cheaper for COP.
Supporting Metrics